Björklund Pharma

  • Home
  • Company
  • Science & Innovation
  • Publications
  • Media
  • Contact
    • Contact Form

Immunology

Product Candidate

Thymosin Beta 4 in Inflammatory Conditions

Björklund Pharma AS focuses on thymosin beta 4 (Tβ4), a naturally occurring and highly conserved molecule with potent anti-inflammatory and wound healing properties (1). Tβ4 stimulates dermal wound healing, suppresses pro-inflammatory signaling pathways and gene expression profiles, ameliorates end-organ tissue damage, and promotes repair.

Tβ4 is clinically relevant in a wide array of systemic inflammatory conditions. It inhibits the activation and nuclear translocation of transcription factor nuclear factor kappa B (NFκB), a major regulator of the inflammatory response.

References

1. Bjørklund G, Dadar M, Aaseth J, Chirumbolo S. Thymosin β4: a multi-faceted tissue repair stimulating protein in heart injury. Curr Med Chem 2020; 27(37): 6294-6305.

Recent Posts

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment
  • Email
  • Facebook
  • Google+
  • LinkedIn
  • Twitter
  • YouTube

RSS CONEM News

  • DAJTEMU
  • Better Brain Health – We Are What We Eat
  • Zinc, Copper, and Autism Spectrum Disorder
  • Nutritional Minerals and the Periodic Table
  • Semey Revisited: The legacy of nuclear testing in Kazakhstan

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2023 Björklund Pharma AS